Takara Bio Valuation
| TF2 Stock | EUR 5.00 0.40 7.41% |
At this time, the company appears to be overvalued. Takara Bio has a current Real Value of €4.04 per share. The regular price of the company is €5.0. Our model measures the value of Takara Bio from inspecting the company fundamentals such as Shares Outstanding of 120.42 M, return on equity of -0.068, and Operating Margin of (0.26) % as well as reviewing its technical indicators and probability of bankruptcy.
Price Book 1.1522 | Enterprise Value 470.8 M | Enterprise Value Ebitda 209.857 | Price Sales 0.0147 | Enterprise Value Revenue 1.9379 |
Overvalued
Today
Please note that Takara Bio's price fluctuation is unstable at this time. Calculation of the real value of Takara Bio is based on 3 months time horizon. Increasing Takara Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Takara stock is determined by what a typical buyer is willing to pay for full or partial control of Takara Bio. Since Takara Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Takara Stock. However, Takara Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.0 | Real 4.04 | Hype 5.0 |
The real value of Takara Stock, also known as its intrinsic value, is the underlying worth of Takara Bio Company, which is reflected in its stock price. It is based on Takara Bio's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Takara Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Takara Bio helps investors to forecast how Takara stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Takara Bio more accurately as focusing exclusively on Takara Bio's fundamentals will not take into account other important factors: Takara Bio Cash |
|
About Takara Bio Valuation
The stock valuation mechanism determines Takara Bio's current worth on a weekly basis. Our valuation model uses a comparative analysis of Takara Bio. We calculate exposure to Takara Bio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Takara Bio's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 30 B | 27.4 B |
Takara Bio Quarterly Retained Earnings |
|
Complementary Tools for Takara Stock analysis
When running Takara Bio's price analysis, check to measure Takara Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Takara Bio is operating at the current time. Most of Takara Bio's value examination focuses on studying past and present price action to predict the probability of Takara Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Takara Bio's price. Additionally, you may evaluate how the addition of Takara Bio to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |